Avidity Biosciences Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Avidity Biosciences Inc
Access all reports
Avidity Biosciences Inc is a biopharmaceutical company focused on developing a novel class of RNA therapeutics. These therapeutics, known as Antibody Oligonucleotide Conjugates (AOC™), are designed to target and treat a range of serious diseases by combining the specificity of monoclonal antibodies with the precision of oligonucleotides. This approach aims at addressing diseases previously untreatable with RNA therapeutics. The company is headquartered in San Diego, California, and its shares are listed on the Nasdaq.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States